Stockadora

8-K filings / November 18, 2026

Merck & Co., Inc.: A change of officers or directors

Merck & Co., Inc. filed a current report (Form 8-K) with the SEC on November 18, 2026. It reports a change of officers or directors.

AI-written from the facts below

In plain English

Thomas H. Glocer is leaving the board of directors. This board change is reported under Item 5.02 of Form 8-K, the section covering directors and senior officers who leave or are appointed to their roles.

What each sentence states
“Thomas H. Glocer is leaving the board of directors.”
  • Item 5.02: Thomas H. Glocer leaves the board of directors.
“This board change is reported under Item 5.02 of Form 8-K, the section covering directors and senior officers who leave or are appointed to their roles.”
  • Item 5.02: Thomas H. Glocer leaves the board of directors.
  • Item 5.02 of Form 8-K covers directors and senior officers who leave or are appointed.
Written by an AI model from the facts on this page only; code and a second model checked every sentence against them.

Item 5.02

Officers and directors

  • Leaves Thomas H. Glocer, Director From the filing
    Source
    “(b) On November 16, 2026, Thomas H. Glocer gave notice to Merck & Co., Inc. (the “Company”) of his intention to retire from the Board of Directors of the Company (the “Board”) as of the Company’s 2027 Annual Meeting of Shareholders.”
    Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov

Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.